TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
SNWV

SANUWAVE Health, Inc.

Healthcare · Medical Devices

5.20$ -2.3% vs. previous close Closing price · As of: Oct 30, 2026

Ownership

Ownership Structure

Who owns SANUWAVE Health, Inc. (SNWV)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 71.9% of the shares are freely tradable; institutional investors hold 47.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 47.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 71.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 4.3%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 9Mio.

Largest Shareholders

Institutions

Institutions SNWV
Name Stake (%) Shares Change (%) Date
Solas Capital Management LLC 7.10 610,968 +112.5 06/30/2026
Awm Investment Company Inc 5.28 454,550 +0.0 06/30/2026
Praetorian PR LLC 4.59 395,000 +12.9 06/30/2026
Vanguard Capital Management, LLC 4.10 352,756 +1.1 06/30/2026
Opaleye Management Inc 3.56 306,140 -68.8 06/30/2026
UBS Group AG 2.99 256,791 +22.1 06/30/2026
BlackRock Inc 1.86 159,867 -66.8 06/30/2026
Geode Capital Management, LLC 1.00 86,098 -49.9 06/30/2026
Citadel Advisors Llc 0.69 59,473 +228.6 06/30/2026

Funds

Funds SNWV
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 3.08 264,933 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?